NCT01927432

Brief Summary

In women with regular menstrual cycles, antral follicles have been shown to grow in synchronous cohorts, called waves, 2-3 times in a menstrual cycle. It is unknown whether these waves of follicle growth also occur in women with amenorrhea or if there is abnormal/absent follicle growth. Further, oligo- or amenorrhea has been associated with metabolic disturbances, such as over- or under-nutrition, central obesity and insulin resistance. Yet, mechanisms whereby metabolic factors influence folliculogenesis in women are poorly understood. To understand potential mechanisms, the investigators plan to characterize follicle growth dynamics in women with or without regular menstrual cycles and identifying key metabolic differences in these women which may be important in normal follicle development and fertility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 22, 2013

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

10 years

First QC Date

August 20, 2013

Last Update Submit

February 8, 2024

Conditions

Keywords

Polycystic Ovary Syndrome (PCOS)NutritionMetabolismAntral follicle growthMenstrual Cyclicity

Outcome Measures

Primary Outcomes (2)

  • Follicle number

    The number of all antral follicles in each ovary will be determined using ultrasonography for each participant. Changes in follicle number over time will be compared between groups.

    4-5 weeks

  • Follicle diameter

    The diameter of all follicles \>2mm will be determined using ultrasonography for each participant. Changes in follicle diameter over time will be compared between groups.

    4-5 weeks

Secondary Outcomes (16)

  • Ovarian Volume

    4-5 weeks

  • Anti-Müllerian hormone

    4-5 weeks

  • Serum FSH concentration

    4-5 weeks

  • Serum LH concentration

    4-5 weeks

  • Serum progesterone concentration

    4-5 weeks

  • +11 more secondary outcomes

Study Arms (2)

Regular menstrual cycles

Adult women will be assigned to this category if they report a history of regular menstrual cycles.

Irregular menstrual cycles

Adult women will be assigned to this category if they report a history of irregular menstrual cycles, including women with a pre-existing diagnosis of PCOS.

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women must be able to transport to Cornell University in Ithaca, NY. Eligible participants are between 18-35 years with a BMI of 18 kg/m2 or higher. Women are screened and enrolled following consent based on their response to our advertisements. Enrollment is restricted to the geographical area.

You may qualify if:

  • Between 18 and 35 years
  • BMI ≥ 18 kg/m2
  • If ≥ 21 years old, must have had healthy pelvic exam w/in past 2 years
  • Either:
  • Regular menstrual cycles (21-35 days);
  • Irregular menstrual cycles (\>36 days) with or without a previous diagnosis of PCOS from a primary care provider

You may not qualify if:

  • Current use of medication(s) known or suspected to interfere with reproductive function (eg. oral contraceptives) or insulin sensitivity
  • Pregnant or breastfeeding
  • Not otherwise healthy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Metabolic Research Unit, Cornell University

Ithaca, New York, 14853, United States

Location

Related Publications (2)

  • Oldfield AL, Carter FE, Reeves RE, Jarrett BY, Vanden Brink H, Lujan ME. Impact of a hypocaloric dietary intervention on antral follicle dynamics in eumenorrheic women with obesity. Hum Reprod. 2024 Apr 3;39(4):801-811. doi: 10.1093/humrep/deae017.

  • Oldfield AL, Vanden Brink H, Carter FE, Jarrett BY, Lujan ME. Obesity is associated with alterations in antral follicle dynamics in eumenorrheic women. Hum Reprod. 2023 Mar 1;38(3):459-470. doi: 10.1093/humrep/dead007.

Biospecimen

Retention: SAMPLES WITH DNA

Blood serum, subcutaneous fat

MeSH Terms

Conditions

OligomenorrheaAmenorrheaPolycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsOvarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Marla E. Lujan, PhD

    Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2013

First Posted

August 22, 2013

Study Start

September 1, 2011

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

February 9, 2024

Record last verified: 2024-02

Locations